Price $255.18 |
Market Cap
67.9B
|
Sector Health Care |
Div. Growth
2.70%
|
|
P/E
51.8
|
P/B
3.15
|
P/S
3.94
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
64.2
|
Op. Cash Flow
2.88M
|
FCF
3.8
|
|
Op. Margin
12.40%
|
Net Margin
5.40%
|
ROE
4.40%
|
ROI
3.00%
|
|
ROA
1.70%
|
EPS Growth
912.90%
|
Current Ratio
1.0
|
Debt/Equity
90.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MTBC Inc (MTBC) | $4.52 | - | - | 58.6M | Strong Buy |
| Lannett Company, Inc. (LCI) | $6.86 | - | - | 258.4M | Strong Buy |
| IRIDEX Corporation (IRIX) | $2.55 | - | - | 47.2M | Strong Buy |
| Apollo Endosurgery Inc (APEN) | $3.32 | - | - | 61.4M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.52 | - | - | 208.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
